Screening for encephalitis-causing autoantibodies in serum and CSF of first-episode psychosis patients and controls

Screening for encephalitis-causing autoantibodies in serum and CSF of first-episode psychosis patients and controls

Bibliographic Details
Main Authors:	Theorell, J, Ramberger, M, Harrison, R, Mgbachi, V, Jacobson, L, Waters, P, Cervenka, S, Irani, SR, Piehl, F
Format:	Conference item
Language:	English
Published:	Wiley 2020

Similar Items

Screening for pathogenic neuronal autoantibodies in serum and CSF of patients with first-episode psychosis
by: Jakob Theorell, et al.
Published: (2021-11-01)

CSF levels of synaptosomal-associated protein 25 and synaptotagmin-1 in first-episode psychosis subjects
by: Chengai Xu, et al.
Published: (2020-06-01)

Autoantibody-mediated encephalitis
by: Irani, S
Published: (2017)

CXCL13 levels and autoantibody epitope specificities in LGI1-autoantibody syndromes
by: Michael, S, et al.
Published: (2019)

Disease-relevant autoantibodies in first episode schizophrenia.
by: Zandi, MS, et al.
Published: (2011)

Plasma bilirubin levels are reduced in first-episode psychosis patients and associates to working memory and duration of untreated psychosis
by: Meneca Becklén, et al.
Published: (2021-04-01)

Potentially pathogenic autoantibodies associated with epilepsy and encephalitis in children and adults.
by: Vincent, A, et al.
Published: (2011)

Identification of cerebrospinal fluid and serum metabolomic biomarkers in first episode psychosis patients
by: Pei Shang, et al.
Published: (2022-06-01)

The B cell immunobiology that underlies CNS autoantibody-mediated diseases
by: Sun, B, et al.
Published: (2020)

Do neuronal autoantibodies cause psychosis? a neuroimmunological perspective
by: Coutinho, E, et al.
Published: (2014)

Do neuronal autoantibodies cause psychosis? A neuroimmunological perspective.
by: Coutinho, E, et al.
Published: (2014)

Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis
by: Pollak, TA, et al.
Published: (2020)

Real-world prevalence of autoantibodies in epilepsy
by: McGinty, RN, et al.
Published: (2020)

Absence of neuronal autoantibodies in neuropsychiatric systemic lupus erythematosus
by: Varley, JA, et al.
Published: (2020)

Linear- versus conformational-protein directed autoantibodies in neuropsychiatric systemic lupus erythematosis
by: Varley, J, et al.
Published: (2017)

Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2
by: Michael, S, et al.
Published: (2020)

A tumultuous case of episodic apnoea
by: Sun, B, et al.
Published: (2019)

Autoantibodies associated with diseases of the CNS: new developments and future challenges.
by: Vincent, A, et al.
Published: (2011)

Time for a change of practice: the real-world value of testing for neuronal autoantibodies in acute first-episode psychosis
by: Pollak, T, et al.
Published: (2018)

Time for a change of practice: the real-world value of testing for neuronal autoantibodies in acute first-episode psychosis
by: Thomas A. Pollak, et al.
Published: (2018-07-01)

Serum Systemic Autoantibodies in Anti-N-Methyl-D-Aspartate Receptor Encephalitis
by: Bingjun Zhang, et al.
Published: (2020-02-01)

Autoantibody-mediated neurological diseases
by: Varley, JA, et al.
Published: (2020)

CXCL13 levels in LGI1-and CASPR2-autoantibody syndromes
by: Michael, S, et al.
Published: (2019)

Antibody-mediated encephalitis and psychosis.
by: Pollak, T, et al.
Published: (2012)

NMDA receptor antibody related encephalitis
by: Irani, SR
Published: (2012)

First-episode psychosis: An update
by: Bonga Chiliza, et al.
Published: (2008-03-01)

Controversies in the detection of neural autoantibodies
by: Philippa Pettingill, et al.
Published: (2016-09-01)

Facial affect recognition in first-episode psychosis is impaired but not associated with psychotic symptoms
by: Cornelia Larsson, et al.
Published: (2022-09-01)

Autoantibody testing in encephalopathies.
by: Lee, R, et al.
Published: (2012)

ANTI-GAD65, NMDAR AND VGKC ANTIBODIES DETECTED IN FIRST EPISODE PSYCHOSIS
by: Lennox, B, et al.
Published: (2009)

The clinical relevance of serum versus CSF NMDAR autoantibodies associated exclusively with psychiatric features: a systematic review and meta-analysis of individual patient data
by: Blackman, G, et al.
Published: (2022)

The clinical relevance of serum versus CSF NMDAR autoantibodies associated exclusively with psychiatric features: a systematic review and meta-analysis of individual patient data
by: Lim, MF, et al.
Published: (2023)

Autoimmune encephalitis
by: Irani, SR, et al.
Published: (2011)

Autoimmune encephalitis.
by: Irani, SR, et al.
Published: (2011)

Neuronal autoantibodies and blood-brain barrier disruption in subjects at ultra-high risk for psychosis
by: Pollak, T, et al.
Published: (2017)

Episodic bradycardia as neurocardiac prodrome to voltage-gated potassium channel complex/leucine-rich, glioma inactivated 1 antibody encephalitis.
by: Naasan, G, et al.
Published: (2014)

NMDA receptor antibody encephalitis.
by: Irani, SR, et al.
Published: (2011)

CSF metabolic and proteomic profiles in patients prodromal for psychosis.
by: Jeffrey T-J Huang, et al.
Published: (2007-01-01)

Detection and significance of neuronal autoantibodies in patients with meningoencephalitis in Vientiane, Lao PDR
by: Uy, CE, et al.
Published: (2022)

COMPARISON OF EFFECT OF OLANZAPINE AND RESPERIDONE ON SERUM PROLACTIN LEVELS IN PATIENTS WITH FIRST EPISODE PSYCHOSIS
by: Muhammad Haroon Khattak, et al.
Published: (2018-12-01)